Bill Text: NY S07694 | 2021-2022 | General Assembly | Introduced

---

Bill Title: Relates to the screening of newborns for glucose-6-phosphate dehydrogenase deficiency.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Passed) 2022-02-24 - SIGNED CHAP.70 [S07694 Detail]

Download: New_York-2021-S07694-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          7694

                    IN SENATE

                                     January 7, 2022
                                       ___________

        Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
          printed to be committed to the Committee on Rules

        AN ACT to amend the public health law, in relation to newborn  screening
          for glucose-6-phosphate dehydrogenase deficiency

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph (j) of subdivision 1 of  section  2500-a  of  the
     2  public  health  law,  as added by a chapter of the laws of 2021 amending
     3  the public health law relating to newborn screening for  adrenoleukodys-
     4  trophy  and glucose-6-phosphate dehydrogenase deficiency, as proposed in
     5  legislative bills numbers A. 4572 and S. 4316, is  amended  to  read  as
     6  follows:
     7    (j)  Glucose-6-phosphate dehydrogenase deficiency using a quantitative
     8  enzymatic test or other diagnostic test  in  cases  where:  the  newborn
     9  infant  presents with hemolytic anemia, hemolytic jaundice, or early-on-
    10  set increasing neonatal jaundice, that  is,  jaundice  (bilirubin  level
    11  greater than fortieth percentile for age in hours) persisting beyond the
    12  day  of  birth through the week after birth; the newborn infant has been
    13  admitted to the hospital for jaundice following birth; or the biological
    14  parent of the newborn infant indicates a family, racial, or ethnic  risk
    15  of   glucose-6-phosphate   dehydrogenase  deficiency,  including  having
    16  significant African, Asian, Mediterranean, or Middle Eastern ancestry.
    17    § 2. This act shall take effect on the  same  date  and  in  the  same
    18  manner  as  a chapter of the laws of 2021 amending the public health law
    19  relating   to   newborn   screening   for    adrenoleukodystrophy    and
    20  glucose-6-phosphate dehydrogenase deficiency, as proposed in legislative
    21  bills numbers A. 4572 and S.  4316, takes effect. Effective immediately,
    22  the commissioner of health shall make regulations and take other actions
    23  reasonably necessary to implement this act on that date.


         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD00136-02-2